BusinessNew U.S. Patent Allowance Granted to AXIM® Biotech for Use of All Cannabinoids in Its Controlled-Release Chewing Gum ProductsBy Nasdaq OMXNov 16, 2016, 2:01 PM UTC
BusinessNew U.S. Patent Allowance Granted to AXIM® Biotech for Use of All Cannabinoids in Its Controlled-Release Chewing Gum ProductsBy Nasdaq OMXNov 16, 2016, 2:01 PM UTC
BusinessAXIM Biotechnologies, Inc. CEO to Speak on Emerging Markets and Cannabis Drug Market at Money Show DallasBy Nasdaq OMXOct 19, 2016, 1:02 PM UTC
BusinessAXIM Biotechnologies, Inc. CEO to Speak on Emerging Markets and Cannabis Drug Market at Money Show DallasBy Nasdaq OMXOct 19, 2016, 1:02 PM UTC
BusinessAXIM Biotechnologies, Inc. CEO to Speak at First-Ever National Symposium on Medical Cannabis for Healthcare Professionals in Mexico CityBy Nasdaq OMXOct 6, 2016, 1:00 PM UTC
BusinessAXIM® Biotech Signs Exclusive Distribution Agreement With Israel’s Rafa PharmaceuticalsBy Nasdaq OMXSep 19, 2016, 1:00 PM UTC
BusinessAXIM Biotech CEO Appointed to American Pain Association Board of Advisors, Addresses American Opioid Abuse EpidemicBy Nasdaq OMXMar 31, 2016, 1:00 PM UTC
BusinessAXIM Biotech Leads Cannabis Industry in Cannabinoid Research, Development and Intellectual Property; Tackles 15 Debilitating Conditions With No Known CureBy Nasdaq OMXFeb 18, 2016, 2:00 PM UTC
